STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 5.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $256,000 | -55.1% | 52,863 | -1.3% | 0.00% | -100.0% |
| Q4 2019 | $570,000 | +9.2% | 53,583 | +7.0% | 0.00% | 0.0% |
| Q3 2019 | $522,000 | +60.1% | 50,097 | +135.1% | 0.00% | – |
| Q2 2019 | $326,000 | +27.8% | 21,309 | +7.2% | 0.00% | – |
| Q1 2019 | $255,000 | +35.6% | 19,882 | +0.5% | 0.00% | – |
| Q4 2018 | $188,000 | -83.7% | 19,774 | -22.5% | 0.00% | -100.0% |
| Q3 2013 | $1,155,000 | – | 25,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |